On Wednesday, 12 November 2025, Rhythm Pharmaceuticals (NASDAQ:RYTM) presented at the Guggenheim Securities 2nd Annual Healthcare Innovation Conference. The discussion highlighted the company’s ...

Earnings call Q3 2025 revenue rose 54% YoY to $51.3M, driven by InSibiri uptake in BBS and international expansion. Rhythm is preparing for a December 20 PDUFA decision for acquired hypothalamic ...

Nov 7 (Reuters) - Rhythm Pharmaceuticals (RYTM.O), opens new tab said on Friday the U.S. Food and Drug Administration has extended the review period for expanded approval of its drug to treat a rare ...

The US Food and Drug Administration (FDA) has extended the review period for expanded approval of Rhythm Pharmaceuticals’ Imcivree (setmelanotide) for a form of obesity caused by damage to the brain.

The PDUFA data has been extended from December 20, 2025 to March 20, 2026. The Food and Drug Administration (FDA) has extended the review period for setmelanotide in the treatment of acquired ...

Investing.com -- Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) stock fell 3.4% in premarket trading Friday after the company announced the U.S. Food and Drug Administration (FDA) has extended its review ...

-- Company is on track to report preliminary results from setmelanotide Phase 2 trial in Prader-Willi syndrome in fourth quarter of 2025 -- -- German observational study showed setmelanotide therapy ...

-- Third quarter 2025 net product revenue from global sales of IMCIVREE ® (setmelanotide) of $51.3 million -- -- December 20, 2025 PDUFA goal date set for sNDA for setmelanotide in acquired ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Collection history unknown; formerly ...

A look at the matchup and a key player for nine of the Orange County teams — Villa Park, La Habra, Beckman, Irvine, Brea ...

Back by popular demand after last year’s sold-out shows, the Southampton Arts Center will present four staged readings of Capote’s beloved Christmas short stories.